Európai Unió - spanyol - EMA (European Medicines Agency)

astrazeneca ab - nirsevimab - los sueros inmunes e inmunoglobulinas, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.